Exploring the Role of Glycine Metabolism in Coronary Artery Disease: Insights from Human Genetics and Mouse Models
Nutrients · 06.01.2025 · 17 (1) · 198
DOI: 10.3390/nu17010198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 06.01.2025. Verfasst von Subarna Biswas und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. Hauptthemen laut MEDLINE: Glycine, Coronary Artery Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIEHS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Circulating glycine levels have been associated with reduced risk of coronary artery disease (CAD) in humans but these associations have not been observed in all studies. We evaluated whether the relationship between glycine levels and atherosclerosis was causal using genetic analyses in humans and feeding studies in mice.
Methods
Serum glycine levels were evaluated for association with risk of CAD in the UK Biobank. Genetic determinants of glycine levels were identified through a genome-wide association study (GWAS) and used to evaluate the causal relationship between glycine and risk of CAD by Mendelian randomization (MR). A dietary supplementation study was carried out with atherosclerosis-prone apolipoprotein E deficient (ApoE−/−) mice to determine the effects of increased circulating glycine levels on cardiometabolic traits and aortic lesion formation.
Results
Among 105,718 UK Biobank subjects, elevated serum glycine levels were associated with significantly reduced risk of prevalent CAD (Quintile 5 vs. Quintile 1 OR = 0.76, 95% CI 0.67–0.87; p < 0.0001) and incident CAD (Quintile 5 vs. Quintile 1 HR = 0.70, 95% CI 0.65–0.77; p < 0.0001) after adjustment for age, sex, ethnicity, anti-hypertensive and lipid-lowering medications, blood pressure, kidney function, and diabetes. A GWAS meta-analysis with 230,947 subjects identified 61 loci for glycine levels, of which 26 were novel. MR analyses provided modest evidence that genetically elevated glycine levels were causally associated with reduced systolic blood pressure and risk of type 2 diabetes, but did not provide significant evidence for an association with decreased risk of CAD. Glycine supplementation in mice had no effects on cardiometabolic traits or atherosclerotic lesion development.
Conclusions
While expanding the genetic architecture of glycine metabolism, MR analyses and in vivo feeding studies did not provide evidence that the clinical association of this amino acid with atherosclerosis represents a causal relationship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
- Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
- Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
- Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
- Center for Microbiome and Human Health, Cleveland Clinic, Cleveland, OH 44195, USA.
- Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
ORCID-Profile: Subarna Biswas, James R Hilser, Zeneng Wang, Ina Nemet, Zachary Fouladian, Neal J Spencer, W H Wilson Tang, Aldons J Lusis, Jaana A Hartiala, Hooman Allayee
Förderung
- NIH HHS
- NIEHS NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIH
Zitieren
APA
Biswas, S., Hilser, J. R., Woodward, N. C., Wang, Z., Gukasyan, J., Nemet, I., Schwartzman, W. S., Huang, P., Han, Y., Fouladian, Z., Charugundla, S., Spencer, N. J., Pan, C., Tang, W. H. W., Lusis, A. J., Hazen, S. L., Hartiala, J. A., & Allayee, H. (2025). Exploring the Role of Glycine Metabolism in Coronary Artery Disease: Insights from Human Genetics and Mouse Models. Nutrients, 17(1), 198. https://doi.org/10.3390/nu17010198
Vancouver
Biswas S, Hilser JR, Woodward NC, Wang Z, Gukasyan J, Nemet I, et al. Exploring the Role of Glycine Metabolism in Coronary Artery Disease: Insights from Human Genetics and Mouse Models. Nutrients. 2025;17(1):198. doi:10.3390/nu17010198
BibTeX
@article{Biswas2025,
author = {Biswas, Subarna and Hilser, James R and Woodward, Nicholas C and Wang, Zeneng and Gukasyan, Janet and Nemet, Ina and Schwartzman, William S and Huang, Pin and Han, Yi and Fouladian, Zachary and Charugundla, Sarada and Spencer, Neal J and Pan, Calvin and Tang, W H Wilson and Lusis, Aldons J and Hazen, Stanley L and Hartiala, Jaana A and Allayee, Hooman},
title = {Exploring the Role of Glycine Metabolism in Coronary Artery Disease: Insights from Human Genetics and Mouse Models},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {1},
pages = {198},
doi = {10.3390/nu17010198}
}
EUVIMED